by According to Precedence Research, during the forecast period of 2021 to 2030, the global medical affairs outsourcing market is estimated to develop at a compound annual growth rate (CAGR) of 12.5%. The global medical affairs outsourcing market was valued at USD 1.45 billion in 2021, and it is predicted to exceed USD 3.51 billion by 2030. The study investigates several elements and their consequences on the growth of the medical affairs outsourcing market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1113
Growth Factor
The global medical affairs outsourcing market is propelled by escalating research and developments undertakings along with growing spending in the healthcare sector across the globe. Further rising emphasis on CROs and CMOs is supporting the market growth across different economies in the world. Geographically, Asia Pacific is expected projected show significant growth in the global market on account of fast turnaround period and stress-free obtainability of the trained and skilled professionals at low cost. Furthermore, augmented clinical trials across the world are also triggering the growth of global medical affairs outsourcing market. As per statistics offered by Word Health organization, the yearly number of registered clinical trials augmented from 3,344 in year 2004 to around 54,894 in the year 2018. As medical affair is significant support action for a successful clinical trial, its cumulative number is predicted to flourish growth of medical affairs outsourcing market during the years to come.
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1113
This report focuses on medical affairs outsourcing market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall medical affairs outsourcing market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Report Highlights
- In 2019, medical writing & publishing appeared as most promising segment and garnered maximum revenue share of the total market
- Cumulative R&D activities and expansion of novel products to lift the growth of medical regulatory affairs outsourcing market across the world
- Pharmaceutical industry segment conquered the global market by accounting prominent share more than 50% of the total revenue generated by market in 2019.
- The Medical Science Liaisons (MSLs) services segment projected to record firmest CAGR during assessment period.
Regional Snapshots
North America occupied for the prominent revenue chunk of the total gathered by global medical affairs outsourcing market in 2019 across various segments. This region is foreseen to sustain this stronghold during next few years on account of existence of leading global life sciences and pharmaceutical organizations, rigorous regulators such as FDA and obtainability of skilled workforce pool across the region.
Asia Pacific is projected to record the utmost compounded annual growth throughout the estimate period due to contributing factors such as accessibility of low-cost labor and intensifying cases of regulatory filings. Expansion of pharmaceutical and leading life science firms in this region is further estimated to bolster demand for medical affair outsourcing in Asia Pacific. Asia Pacific is the firmest growing pharmaceutical sector across the world, offering noteworthy prospects for drug marketing and development. Accordingly, pharmaceutical regulations in APAC are attaining attention amongst pharmaceutical businesses worldwide
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of medical affairs outsourcing, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of medical affairs outsourcing has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the medical affairs outsourcing market.
Some of the prominent players in the medical affairs outsourcing market include:
- ICON plc
- Wuxi Clinical Development, Inc
- Pharmaceutical Product Development, LLC
- Ashfield Healthcare Communications
- Indegene Inc.
- IQVIA Holdings Inc
- The Medical Affairs Company (TMAC)
- SGS SA
- Syneos Health Inc
- ZEINCRO Group
Segments Covered in the Report
By Services
- Medical Monitoring
- Medical Writing & Publishing
- Medical Information
- Medical Science Liaisons
- Others
By Industry
- Medical Devices
- Pharmaceutical
- Biopharmaceutical
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Medical Affairs Outsourcing Market, By Services
7.1. Medical Affairs Outsourcing Market, by Services Type, 2021-2030
7.1.1. Medical Monitoring
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Medical Writing & Publishing
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Medical Information
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Medical Science Liaisons
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Medical Affairs Outsourcing Market, By Industry
8.1. Medical Affairs Outsourcing Market, by Industry, 2021-2030
8.1.1. Medical Devices
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Pharmaceutical
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Biopharmaceutical
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Medical Affairs Outsourcing Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.2. Market Revenue and Forecast, by Industry (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Industry (2017-2030)
Chapter 10. Company Profiles
10.1. ICON plc
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Wuxi Clinical Development, Inc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Pharmaceutical Product Development, LLC
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Ashfield Healthcare Communications
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Indegene Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. IQVIA Holdings Inc
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. The Medical Affairs Company (TMAC)
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. SGS SA
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Syneos Health Inc
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. ZEINCRO Group
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1113
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
